Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759
Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy
Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY

J RADIAT RES 2019 10.1093/jrr/rrz040
Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score
Kim1, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D

CANCER RES TREAT 2019 10.4143/crt.2018.366
Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
Lee1, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K

CANCER RES TREAT 2019 10.4143/crt.2018.125
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Park1, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

J RADIAT RES 2019 10.1093/jrr/rry102
Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

RADIAT ONCOL 2019 10.1186/s13014-019-1221-4
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy
Kim1, H; Pyo, H; Noh, JM; Lee, W; Park, B; Park, HY; Yoo, H

PHYS MEDICA 2018 10.1016/j.ejmp.2018.10.009
Investigations of line scanning proton therapy with dynamic multi-leaf collimator
Kim1, DH; Park, S; Jo, K; Cho, S; Shin, E; Lim, DH; Pyo, H; Han, Y; Suh, TS

Journal of thoracic disease 2018 10.21037/jtd.2018.04.127
The more and the heavier may not always be an answer
Pyo1, H; Lee, SH; Kim, J

LUNG CANCER 2018 10.1016/j.lungcan.2017.11.020
Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer
Lee1, J; Kim, HK; Park, BJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Pyo, H; Ahn, YC; Ahn, JS; Ahn, MJ; Park, K; Kim, J

J THORAC ONCOL 2017 10.1016/j.jtho.2017.09.1954
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
Sun1, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K

RADIAT ONCOL 2017 10.1186/s13014-017-0905-x
Normal lung sparing Tomotherapy technique in stage III lung cancer
Hong1, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K

CANCER RES TREAT 2017 10.4143/crt.2016.442
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience
Park1, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922.
Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation
Oh D11, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.

J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14.
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?
Kim H11, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.

Cancer Res Treat. 2016 Oct;48(4):1187-1195. Epub 2016 Mar 9.
Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules
Cho WK11, Noh JM1, Ahn YC1, Oh D1, Pyo H1.

Strahlenther Onkol. 2016 Sep;192(9):649-57. doi: 10.1007/s00066-016-0985-9. Epub 2016 Jun 9.
Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas
Lee SU11, Moon SH2,3,4, Cho KH1, Pyo HR5, Kim JY1, Kim DY1, Kim TH1, Suh YG1, Kim YJ1.

Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12.
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Noh JM11, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.

Cancer Res Treat. 2015 Oct;47(4):645-52. doi: 10.4143/crt.2014.144. Epub 2015 Feb 12.
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
Noh JM11, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.

없음
Radical prostatectomy versus external beam radiotherapy for localized prostate cancer Comparison of treatment outcomes
Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10.
Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery
Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.